OtherClinical Investigations (Human)

GRPr antagonist 68Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients

Ingrid L Bakker, Alida C Fröberg, Martijn B Busstra, J. Fred Verzijlbergen, Mark Konijnenberg, Geert J. L. H. van Leenders, Ivo G Schoots, Erik de Blois, Wytske M van Weerden, Simone U Dalm, Theodosia Maina-Nock, Berthold Artur Nock and Marion de Jong
Journal of Nuclear Medicine March 2021, jnumed.120.258814; DOI: https://doi.org/10.2967/jnumed.120.258814

Article Information

jnumed.120.258814
DOI 
https://doi.org/10.2967/jnumed.120.258814
PubMed 
33789933
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online March 31, 2021.
Copyright & Usage 
Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Ingrid L Bakker1,
  2. Alida C Fröberg1,
  3. Martijn B Busstra1,
  4. J. Fred Verzijlbergen1,
  5. Mark Konijnenberg1,
  6. Geert J. L. H. van Leenders1,
  7. Ivo G Schoots1,
  8. Erik de Blois1,
  9. Wytske M van Weerden1,
  10. Simone U Dalm1,
  11. Theodosia Maina-Nock2,
  12. Berthold Artur Nock2 and
  13. Marion de Jong1
  1. 1 Erasmus MC, Netherlands;
  2. 2 NCSR "Demokritos", Greece
  1. For correspondence or reprints contact: Marion de Jong, Erasmus MC, PO box 2040, Room No Na2503, Rotterdam 3000 CA, Netherlands. E-mail: m.hendriks-dejong@erasmusmc.nl

Article usage

Article usage: March 2021 to March 2021

AbstractFullPdf
Mar 20217302
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords